Company Filing History:
17 out of 3,687 
3 out of 3 
1 out of 509 
Years Active: 2003-2022
Title: Innovator Spotlight: Francis Lee from Yardley, PA
Introduction
Francis Lee, an accomplished inventor based in Yardley, PA, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 21 patents, his innovations focus primarily on novel therapeutic compounds aimed at addressing critical health challenges, particularly in the treatment of cancer and infectious diseases.
Latest Patents
Among his latest patents, Francis Lee has developed innovative carbamate and urea compounds designed as multikinase inhibitors. This groundbreaking work details methods for preparing these compounds, as well as their pharmaceutical compositions and potential applications for treating various diseases associated with kinases. Furthermore, he has patented cyclic compounds that serve as immunomodulating agents, particularly novel IDO inhibitors. This patent outlines methods for preparing these inhibitors and discusses their use in treating cancer, infectious diseases, and other disorders.
Career Highlights
Throughout his career, Francis has contributed his expertise to leading pharmaceutical companies. He has worked with Bristol-Myers Squibb Company, where he was involved in the research and development of innovative therapies. Additionally, his tenure at Angex Pharmaceutical, Inc. allowed him to further explore his passion for creating impactful pharmaceutical solutions.
Collaborations
Collaboration has played a vital role in Francis Lee's journey as an inventor. He has worked alongside notable professionals, including Ashvinikumar V Gavai and George V Delucca. These partnerships have helped foster an environment of creativity and innovation, leading to the successful development of his patented inventions.
Conclusion
Francis Lee's contributions to the pharmaceutical industry highlight his commitment to driving innovation and improving health outcomes. With his 21 patents and continued efforts in researching advanced therapeutic compounds, he remains a key figure in the evolution of medical treatments, demonstrating the importance of inventive thinking in addressing public health challenges.